PHONE:  03 9700 7666


Dr Thilinie De Silva

MBChB, FRACP


 

Dr Thilinie De Silva is a staff specialist at St Vincent’s Hospital. She studied undergraduate medicine at the University of Otago in New Zealand, subsequently completing her specialty training at Monash Health and St Vincent’s Hospital.

Dr De Silva has interests in several rheumatology fields, including inflammatory arthritis, connective tissue diseases and osteoarthritis, which have complemented her research interests. She has presented her research in osteoarthritis at local and international conferences. Dr De Silva has worked as a clinical trials sub-investigator at the Emeritus Research Institute in Melbourne. 

Outside of work, Dr De Silva enjoys spending time with her family with a bit of kayaking on the side.

 

Publications:

De Silva T, Pham C, Le Marshall K, Rischin A, Vogrin S, Leung A, Lim K. Quantifying Knee Joint Effusions with Clinical Tests, Musculoskeletal Ultrasound and Synovial Fluid Aspiration: A Prospective Cohort Study. Int J Rheum Dis. 2019; 22(S3): 40-226.

De Silva T, Rischin A. Crowned Dens Syndrome Illustrated on Dual Energy Computed Tomography. Journal of Clinical Rheumatology. 2019;26(8):e293.

De Silva T, Rischin A, Le Marshall K, Leung A, Hor C. Myositis as the presenting feature of ANCA-associated vasculitis: a local experience and literature review. Int J Rheum Dis. 2019; 22(S3): 40-226. 

De Silva T, Lim K. Controversies in osteoarthritis treatment: an in depth look at platelet rich plasma, stem cell therapy and pentosan. Int J Rheum Dis. 2018; 21(S1): 3-22.

De Silva T, Rischin A, Le Marshall K. Reversible eruption of neurofibromatosis associated with tofacitinib therapy for rheumatoid arthritis. Rheumatology (Oxford). 2019; 58(6): 1111-1113.

Antony A, Connelly K, De Silva T, Eades L, Tillett W, Ayoub S et al. Perspectives of Patients With Rheumatic Diseases in the Early Phase of COVID ‐19. Arthritis Care & Research. 2020;72(9):1189-1195.

Liao K, De Silva T. Bonin J, Koelmeyer R, Hoi A. Ro Positivity is an Under-Recognised Poor Prognostic Marker in Systemic Lupus Erythematosus Patients. Arthritis Rheumatol. 2021; 73.

Jiang M, De Silva T, Lim K. Rheumatoid Arthritis in the Elderly. Encyclopedia of Biomedical Gerontology. London: Academic Press; 2019.